116 related articles for article (PubMed ID: 9777371)
1. Androgen regulation of prostate cancer cell FGF-1, FGF-2, and FGF-8: preferential down-regulation of FGF-2 transcripts.
Sarić T; Shain SA
Growth Factors; 1998; 16(1):69-87. PubMed ID: 9777371
[TBL] [Abstract][Full Text] [Related]
2. Exogenous fibroblast growth factors maintain viability, promote proliferation, and suppress GADD45alpha and GAS6 transcript content of prostate cancer cells genetically modified to lack endogenous FGF-2.
Shain SA
Mol Cancer Res; 2004 Nov; 2(11):653-61. PubMed ID: 15561781
[TBL] [Abstract][Full Text] [Related]
3. Neither fibroblast growth factor-1 nor fibroblast growth factor-2 is an androgen receptor coactivator in androgen-resistant prostate cancer.
Shain SA
Mol Urol; 2001; 5(3):121-30. PubMed ID: 11690559
[TBL] [Abstract][Full Text] [Related]
4. Endogenous fibroblast growth factor-1 or fibroblast growth factor-2 modulate prostate cancer cell proliferation.
Shain SA; Sarić T; Ke LD; Nannen D; Yoas S
Cell Growth Differ; 1996 May; 7(5):573-86. PubMed ID: 8732667
[TBL] [Abstract][Full Text] [Related]
5. Androgen receptor expression induces FGF2, FGF-binding protein production, and FGF2 release in prostate carcinoma cells: role of FGF2 in growth, survival, and androgen receptor down-modulation.
Rosini P; Bonaccorsi L; Baldi E; Chiasserini C; Forti G; De Chiara G; Lucibello M; Mongiat M; Iozzo RV; Garaci E; Cozzolino F; Torcia MG
Prostate; 2002 Dec; 53(4):310-21. PubMed ID: 12430142
[TBL] [Abstract][Full Text] [Related]
6. Androgen and fibroblast growth factor (FGF) regulation of FGF receptors in S115 mouse mammary tumor cells.
Ruohola JK; Valve EM; Vainikka S; Alitalo K; Härkönen PL
Endocrinology; 1995 May; 136(5):2179-88. PubMed ID: 7536664
[TBL] [Abstract][Full Text] [Related]
7. Androgenic up-regulation of androgen receptor cDNA expression in androgen-independent prostate cancer cells.
Dai JL; Maiorino CA; Gkonos PJ; Burnstein KL
Steroids; 1996 Sep; 61(9):531-9. PubMed ID: 8883219
[TBL] [Abstract][Full Text] [Related]
8. Protein kinase C-dependent and -independent pathways of signal transduction in prostate cancer cells: fibroblast growth factor utilization of a protein kinase C-independent pathway.
Hrzenjak M; Shain SA
Cell Growth Differ; 1995 Sep; 6(9):1129-42. PubMed ID: 8519690
[TBL] [Abstract][Full Text] [Related]
9. Regulation of a promoter of the fibroblast growth factor 1 gene in prostate and breast cancer cells.
Payson RA; Chotani MA; Chiu IM
J Steroid Biochem Mol Biol; 1998 Aug; 66(3):93-103. PubMed ID: 9719443
[TBL] [Abstract][Full Text] [Related]
10. Regulation of FGF8 expression by the androgen receptor in human prostate cancer.
Gnanapragasam VJ; Robson CN; Neal DE; Leung HY
Oncogene; 2002 Aug; 21(33):5069-80. PubMed ID: 12140757
[TBL] [Abstract][Full Text] [Related]
11. Fibroblast growth factor-2 and TPA enhance prostate-cancer-cell proliferation and activate members of the Ras and PKC signal transduction pathways.
Hrzenjak M; Shain SA
Recept Signal Transduct; 1997; 7(4):207-19. PubMed ID: 9633822
[TBL] [Abstract][Full Text] [Related]
12. Expression of fibroblast growth factor-8 in adult rat tissues and human prostate carcinoma cells.
Schmitt JF; Hearn MT; Risbridger GP
J Steroid Biochem Mol Biol; 1996 Feb; 57(3-4):173-8. PubMed ID: 8645626
[TBL] [Abstract][Full Text] [Related]
13. Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor-I, keratinocyte growth factor, and epidermal growth factor.
Culig Z; Hobisch A; Cronauer MV; Radmayr C; Trapman J; Hittmair A; Bartsch G; Klocker H
Cancer Res; 1994 Oct; 54(20):5474-8. PubMed ID: 7522959
[TBL] [Abstract][Full Text] [Related]
14. Regulation of fibroblast growth factor-like protein(s) in the androgen-responsive human prostate carcinoma cell line LNCaP.
Zuck B; Goepfert C; Nedlin-Chittka A; Sohrt K; Voigt KD; Knabbe C
J Steroid Biochem Mol Biol; 1992 Mar; 41(3-8):659-63. PubMed ID: 1562538
[TBL] [Abstract][Full Text] [Related]
15. Androgen-stimulated human prostate epithelial growth mediated by stromal-derived fibroblast growth factor-10.
Nakano K; Fukabori Y; Itoh N; Lu W; Kan M; McKeehan WL; Yamanaka H
Endocr J; 1999 Jun; 46(3):405-13. PubMed ID: 10503993
[TBL] [Abstract][Full Text] [Related]
16. Interleukin 8 expression regulates tumorigenicity and metastases in androgen-independent prostate cancer.
Inoue K; Slaton JW; Eve BY; Kim SJ; Perrotte P; Balbay MD; Yano S; Bar-Eli M; Radinsky R; Pettaway CA; Dinney CP
Clin Cancer Res; 2000 May; 6(5):2104-19. PubMed ID: 10815938
[TBL] [Abstract][Full Text] [Related]
17. Regulation of steroid glucuronosyltransferase activities and transcripts by androgen in the human prostatic cancer LNCaP cell line.
Guillemette C; Hum DW; Bélanger A
Endocrinology; 1996 Jul; 137(7):2872-9. PubMed ID: 8770908
[TBL] [Abstract][Full Text] [Related]
18. Effect of fibroblastic growth factors (FGF) on steroid UDP-glucuronosyltransferase expression and activity in the LNCaP cell line.
Lévesque E; Beaulieu M; Guillemette C; Hum DW; Bélanger A
J Steroid Biochem Mol Biol; 1998 Jan; 64(1-2):43-8. PubMed ID: 9569009
[TBL] [Abstract][Full Text] [Related]
19. Androgens inhibit the proliferation of a variant of the human prostate cancer cell line LNCaP.
Joly-Pharaboz MO; Soave MC; Nicolas B; Mebarki F; Renaud M; Foury O; Morel Y; Andre JG
J Steroid Biochem Mol Biol; 1995 Oct; 55(1):67-76. PubMed ID: 7577722
[TBL] [Abstract][Full Text] [Related]
20. Alternative splicing of fibroblast growth factor receptor 2 (FGF-R2) in human prostate cancer.
Carstens RP; Eaton JV; Krigman HR; Walther PJ; Garcia-Blanco MA
Oncogene; 1997 Dec; 15(25):3059-65. PubMed ID: 9444954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
